Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine
- 1 November 1993
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Chemotherapy and Pharmacology
- Vol. 32 (6), 455-462
- https://doi.org/10.1007/bf00685890
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude miceInternational Journal of Cancer, 1992
- Effects of CPT‐11 in combination with other anti‐cancer agents in cultureInternational Journal of Cancer, 1992
- Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSABiochemistry, 1990
- Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cellsEuropean Journal of Cancer and Clinical Oncology, 1990
- Transcription generates positively and negatively supercoiled domains in the templateCell, 1988
- Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cellsNature, 1986
- Novobiocin inhibition of DNA excision repair may occur through effects on mitochondrial structure and ATP metabolism, not on repair topoisomerasesCarcinogenesis: Integrative Cancer Research, 1985
- Perfluorochemical Emulsions Can Increase Tumor RadiosensitivityScience, 1984
- Novobiocin inhibition of simian virus 40 DNA replicationNature, 1980
- Mechanism of the reaction catalyzed by the DNA untwisting enzyme: Attachment of the enzyme to 3′-terminus of the nicked DNAJournal of Molecular Biology, 1978